CID 1219971

132304-37-1

Structural Information

Molecular Formula
C10H16N4O2S
SMILES
CCC1=NN=C(S1)NC(=O)CN2CCOCC2
InChI
InChI=1S/C10H16N4O2S/c1-2-9-12-13-10(17-9)11-8(15)7-14-3-5-16-6-4-14/h2-7H2,1H3,(H,11,13,15)
InChIKey
MJIVQZAYPYEAII-UHFFFAOYSA-N
Compound name
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-morpholin-4-ylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

5
References

3
Patents

256.0994 Da
Monoisotopic Mass

0.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 257.10668 156.8
[M+Na]+ 279.08862 162.7
[M-H]- 255.09212 159.7
[M+NH4]+ 274.13322 170.2
[M+K]+ 295.06256 161.2
[M+H-H2O]+ 239.09666 148.2
[M+HCOO]- 301.09760 170.0
[M+CH3COO]- 315.11325 192.4
[M+Na-2H]- 277.07407 157.6
[M]+ 256.09885 156.5
[M]- 256.09995 156.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe